Oxford-Pomezia vaccine, the UK reserves 30 million doses
Great Britain is purchasing 30 million doses of the Coronavirus vaccine developed by the University of Oxford in collaboration with the Italian Advent-IRBM, based in Pomezia (Rome). “The product development is really positive at present. The time has been unbelievably shortened and there is a good chance to have a significant number of doses within the end of September, when we will find out if the vaccine candidate will become a vaccine”, explains Di Lorenzo, President and CEO of IRBM.
Article published on Il Messaggero – 18/05/2020
Read the original article on ilmessaggero.it